OURNAL OF LINICAL NCOLOGY J C O J C O 2010 Media Kit PRINT ADVERTISING ASCO Member Demographics Closing Dates Display Rates Insert Rates Mechanical Requirements Insert Specifications (Click above to jump to desired section) www.jco.ascopubs.org Official Journal of the American Society of Clinical Oncology ADDITIONAL OPPORTUNITIES Best of JCO Series JCO Reprints ASCO Abstracts JCO Bulk Subscriptions (Sales Force) CONTACT INFORMATION ONLINE ADVERTISING Standard Banners Expandable Banners JCO e-TOC’s CLASSIFIED ADVERTISING ONCOLOGY MARKET RESEARCH 2009 JCO Reader Survey 360 o Study in Oncology
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
O
OURNAL OFLINICALNCOLOGY
JCO
JCO
2010 Media KitPRINT ADVERTISING ASCO Member Demographics Closing Dates Display Rates Insert Rates Mechanical Requirements Insert Specifications
(Click above to jump to desired section)
www.jco.ascopubs.org
Official Journal of the American Society of Clinical Oncology
ADDITIONAL OPPORTUNITIES Best of JCO Series JCO Reprints ASCO Abstracts JCO Bulk Subscriptions (Sales Force)
CONTACT INFORMATION
ONLINE ADVERTISING Standard Banners Expandable Banners JCO e-TOC’s
CLASSIFIED ADVERTISINGONCOLOGY MARKET RESEARCH 2009 JCO Reader Survey 360o Study in Oncology
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who treat people with cancer. ASCO is a non-profit organization that was founded in 1964 by a small group of physician members of the AACR - American Association for Cancer Research - who recognized the need for a separate society dedicated to issues unique to clinical oncology. ASCO’s members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clini-cal and translational research, and, ultimately, cures for the many different cancers that strike millions of people around the world every year.
ASCO IS COMMITTED TO:
IMPROVING cancer care preventionADVANCING the education of those professionals caring for cancer patients and supporting the development of clinical cancer researchers.FOSTERING communication among cancer-related medical subspecialties.ADVOCATING public policy that ensures patient access to high-quality cancer care. ASSISTING oncologists in addressing the challenges of the modern-day practice oncology.
THE JOURNAL OF CLINICAL ONCOLOGY:
-JCO is the primary source of scientific discourse for ASCO.-JCO’s goal is to publish the highest quality manuscripts dedicated to clinical research.-Orginal reports remain the focus of the Journal.-JCO categorizes content by disease type.-Scientific communication is enhanced through approprately selected reviews and editorials-The editor of JCO is Dr. Daniel Haller - Hematology/Oncology, University of Pennsylvania Cancer Center, Philadelphia, PA.
Board Certification Medical Oncology 13,312 33.57% Internal Medicine 10,337 26.07 Hematology 6,633 16.73 Radiation Oncology 1,973 4.98 Surgery/Surgical Oncology 1,606 4.05 Other 1,432 3.61 Pediatrics/Pediatric Oncology 969 2.44 Gynecologic Oncology 633 1.60 Laboratory Research 571 1.44 Pharmacology (Clinical) 335 0.84 Biostatistics/Epidemology 252 0.64 Oncology Nursing 243 0.61 Pathology 237 0.60 Health Care Administration 167 0.42 Oncology Pharmacy 175 0.44 Urology/Urologic Oncology 176 0.44 Gastroenterology 158 0.40 Allied Health 116 0.29 Nuclear Medicine 74 0.19 Radiology 74 0.19 Physician’s Assistant 51 0.13 Psychiatry/Psychology 47 0.12 Dermatology 36 0.09 Hospice and Palliative Medicine 40 0.10 Neuro 4 0.01
<Previous 1 2 3 4 5 Next Page>
Primary Activity for All Member Types General Oncology 6,910 11.34% Breast Cancer 5,911 9.70 Leukemia/Lymphoma/Myeloma /MDS 5,835 9.58 Clinical Trials/Biostatistics/Epdiemology 4,126 6.77 Medical Oncology 3,762 6.18 Gastrointestinal Cancer 3,556 5.84 Lung Cancer 3,545 5.82 Genitourinary Cancer 1,746 2.87 Gyn Cancer 1,696 2.78 Pharm/Drug Development 1,614 2.65 Tumor/Molecular Biology/Cytokines 1,484 2.44 Liver and Pancreas Tumors 1,259 2.07 Surgical Oncology 1,215 1.99 Head and Neck Cancer 1,148 1.88 BMT 1,104 1.81 Radiation Oncology 1,078 1.77 Palliative Care/End of Life 1,053 1.73 Other 968 1.68 Biologic Therapy 916 1.59 Cancer Education 926 1.50 Pediatric Cancers 849 1.39 Pain and Symptom Management 838 1.38 Melanoma/Skin Cancer 824 1.35 Sarcoma 755 1.24 Cancer Prevention 717 1.18
Association Membership* American Society of Hematology 33.0% American Association for Cancer Research 32.0% American Medical Association 29.0% American Society for Therapeutic Radiology 9.0% American College of Radiation Oncology 4.0% Other 40.0%
Years in Practice* 1 to 5 years 26.0% 6 to 10 years 7.0% 11 to15 years 4.0% 16 to 20 years 4.0% 21 to 25 years 9.0% 26 to 30 years 9.0% 30 + years 30.0%
Patients Seen Weekly* Less than 20 22.0% 20 to 40 36.0% 41 to 60 22.0% 61 to 80 9.0% 81 to 100 9.0% Over 100 3.0%
*Data from the 2008 Matalia Study
<Previous 1 2 3 4 5 Next Page>
Primary Medical Specialty Medical Oncology/Hematology 8,445 Medical Oncology (only) 6,514 Surgery/Surgical Oncology 2,895 Radiation Oncology 2,172 Pediatric Oncology 1,447 GP/FP/IM 482 Other 2,895
Secondary Medical Specialty Medical Oncology/Hematology 5,067 Medical Oncology (only) 2,895 Surgery/Surgical Oncology 2,412 Pediatric Oncology 1,447 Urologic Oncology 965 Gynecologic Oncology 723 Radiation Oncology 723 Other 10,616
Practice Setting Private Practice (Office or Hospital Based) 10,014 36.83% Academic Medical Center/University 9,793 36.01 Training Program 3,180 11.69 Pharmaceutical/Biotech Company 2,627 9.66 Government Agency 609 2.24 Staff Model HMO 450 1.65 Administration 364 1.34 Laboratory Research 155 0.57
ADDITIONAL RATES:Color (per page): Cover/Preferred Position Rates (non-cancellable, 10% penalty applied):Standard $1,060 a. 2nd Cover: earned rate plus 50%Matched $1,140 b. 3rd Cover: earned rate pus 25%3/4 Color $2,865 c. 4th Cover: earned rate plus 50% d. Page Facing First Text: earned rate plus 30% e. Page Facing Contents: earned rate plus 30% f. Page Facing Preview Contents: earned rate plus 10%
Copies of new inserts must be sent to The Walchli Tauber Group for editorial approval.a. 6-page insert: rates upon request.b. Back-up rates per page: one-half earned B/W rate.c. Larger units, gatefolds, tip-ins, die cuts: rates upon request.d. Special handling charges: for unusual insert handling, rates upon request.
Special Positioning:Rates upon request for unusual positioning.
Full Schedule Incentive — For the advertiser who plans on running a full schedule of 36 insertions, a 30% discount will be applied to all ads placed.
24 Times Incentive — For the advertiser who plans on running 24 insertions, a 25% discount will be applied to all ads placed.
12 Times Incentive — For the advertiser who plans on running 12 insertions, a 10% discount will be applied to all ads placed.
* Incentive programs are not combinable.
Agency Commission:15%. Color charges and position charges are commissionable. Insert charges are also commissionable (excluding back-up charges). All extra charges are non-commissionable.
Journal Trim Size: Type of Binding: a. Journal trims 3/16” off top, 1/8” bottom, gutter Perfect and outside edge.b. Final trim size of publication is 8 1/8” x 10 7/8”. Paper Stock:c. Live matter should be kept to a minimum of a. Cover: 80 lb Sterling with UV coating; Inside 1/2” inside trimmed edges, and a minimum of Pages: 40 lb Velocity Plus 1/2” should be allowed for the bind. b. 4-color process available
a. Sizes: 2-page insert – 8 3/8” x 11 3/16” 4-page insert – 17” x 11 3/16” Larger sizes upon request.
b. Inserts to be supplied folded.
c. Trimming: 3/16” off top, 1/8” bottom, gutter and outside edge; margin for live matter 5/8” inside all edges of untrimmed insert.
d. Stock: 80 lb. text stock maximum
e. Quantity: 30,000 per issue (Full Run) 25,000 per issue (Domestic Run)
f. Copy Clearance: All inserts subject to approval by ASCO. Copy should be supplied to The Walchli Tauber Group prior to printing inserts. Allow three weeks for approval.
Starting immediately JCO will be printing in Lancaster, Pennsylvania. All new inserts need to be directed to:Cadmus Communications/ Cenveo CompanyAttn: Stephanie Metzger (JCO)3575 Hempland RoadLancaster, PA 17601Tel: (717) 285-6720
ELECTRONIC SUBMISSION OF ADS:
JCO is produced digitally and printed direct to plate (DTP). Below is the file format submission information for ads:
• Ads must be submitted as a high-resolution PDF with advertiser name and issue date in the filename.• Upload a high-res PDF to The Walchli Tauber Group Inc. FTP site at ftp://www.wt-group.com — user: wtgroupftp, password: sendfiles• Find the folder for JCO and the issue date for your ad, and copy your high-res PDF into that file.• Send an email to [email protected] saying that you have uploaded the materials.• You also may email the PDF to [email protected] if the file is less than 10 MB.• Ads may be submitted on CD-ROM. WinZip and Stuffit are the only acceptable compression techniques.
Ship to: Roland KeveWalchli-Tauber Group, Inc.2225 Old Emmorton Road, Suite 201 Bel Air, MD 21015
- Creative should clearly state “Roll Over” (or something similar). - A maximum of 30% of the banner can contain a hotspot - Panel should disappear upon user scroll off - Size: 40K max file size - 24/7 Open Ad Stream accept the following: Pointroll, Eyeblaster, Kilpmart, Unicast, Interpolls, United Virtualites Shoskele, Eyewonder, Dart and Atlas Rich Media. - Audio must be user-initiated on mouse click.
Vertical/Horizontal Panel
- Vertical panel will expand to the left of the 160x600 banner. - Vertical expandable panel should not exceed 240x600 pixels in total. - Horizontal panel will expand downward below the 728x90 banner. - Horizontal expandable panel should not exceed 728x180 pixels in total. Changes and CancellationsAll creative materials must be received at least 5 business days prior to the launch of the campaign. If creative is delayed, WTG, Inc. has the right to extend the campaign end date by same number of days creative was delayed.
Rejecting CreativeASCO reserves the right to approve all ad creative’s which will run on JCO.org and JOP.org. ASCO reserves the right to reject any creative that does not follow ASCO’s specs.
Classified advertising is available in Journal of Clinical Oncology for those recruiting personnel with positions sought, fellowships, practices for sale, and academic posts to be filled. Ads are available in two formats: line ads and display ads. All display ads must be approved by ASCO prior to running.
Cancellation requests must be confirmed in writing and will be honored for the next applicable issue. There are no refunds.
Closing Dates
1st 10th 20th 1st 10th 20th JANUARY 12/1 12/10 12/20 JULY 6/1 6/10 6/20
Rates and Information: PRE-PAYMENT IN FULL IS REQUIRED WITH ALL ADS (all major credit cards accepted). Checks should be made payable to American Society of Clinical Oncology and must be received before ad is placed. All line ads will be placed in the first available print issue (10-day run) and will be placed online (10-day run) approximately same day as print date. Line ads are listed alphabetically by state and are NON-COMMISSIONABLE. Blind Box service and bolded ads are available for an additional $45 per issue. Boxed line ads are available for and additional $80 per issue. Please specify the state under which your advertisement should appear and which month(s) you would like it to be in print. Salary amounts may NOT be included in the print version of the ad.
110 days each2Consecutive, 20 days each3Consecutive, 30 days each
Materials: Ads submitted electronically must be in a Word-friendly format. No proofs are available.
1 Print/Online1 2 Print/Online2 3 Print/Online3
1-100 words $555 $1,005 $1,445101-200 words 725 1,170 1,615201-300 words 890 1,335 1,785301-400 words 1,060 1,500 1,950
Rates and Information: Display space is available for those desiring greater visibility or additional space for their message. Three format sizes, 1/4, 1/2, V/H, or full page. PRE-PAYMENT IN FULL IS REQUIRED WITH ALL ADS. Display ads are commissionable. Display ads may be placed online. Please specify format and month(s) to appear.
Materials: Display ads must be submitted as PDF files, preferably 600 dpi minimum. If your ad is being placed online also, you must include a Word-friendly format of your text must be included. E-mail all ads to [email protected].
Online Display Rates (10 days online in addition to the display ad):
Color Rates for Display Ads (all ad sizes):Standard $ 990Matched 1,0653/4 color 2,675
Display Space Dimensions 1x 3x 6x 12x1 page 6.8” x 9.175” $3,145* $3,100* $3,035* $2,975*1/2 horizontal 6.8” x 4.45” 2,055* 1,975* 1,925* 1,900*1/2 vertical 3.25” x 9.175” 2,055* 1,975* 1,925* 1,900*1/4 page 3.25” x 4.45” 1,215* 1,185* 1,160* 1,140**Denotes EACH insertion
Space Cost Full Page $645.00 for 10 days 1/2 Page $430.00 for 10 days1/4 Page $215.00 for 10 days*Word count : 400 words or less
These special promotional issues will contain selected highly-cited premier articles from previous issues of JCO and will be distributed on-site to attendees at this premier oncology meeting.
The content of the articles will relate to the subject matter of these meetings.
ASCO will display a banner ad on JCO.org promoting the publication for a full month prior to the meeting and where to pick up the issues.
The “Best of JCO” issues will not be mailed, only distributed at these meetings from the ASCO Membership Booth and the ASCO Publications Booth and throughout the Fellow’s Lounges
2010 Meetings:GI MeetingGU MeetingAOHA Hematology AssemblyAACR MeetingASCO Annual MeetingBest of ASCO San FranciscoBest of ASCO BostonBreast MeetingECCO/ESMO MeetingMolecular MarkersASH Meeting
Best of JCO Series
Rates:$3,500 GrossFull Page B/W or Four Color (flat rated) *Rates are agency commissionable
Premium Positions:Cover 2: 50% PremiumCover 4: 50% Premium Facing T of C 10% PremiumPage Facing First Text 10% Premium
Your sales force can win the respect and appreciation of medical practitioners by consistently delivering authoritative, respected, and timely information from the pages of Journal of Clinical Oncology.
For complete information about article reprints from Journal of Clinical Oncology, contact:
Terry DennsteadtThe Walchli-Tauber Group, Inc.2225 Old Emmorton Road, Suite 201Bel Air, MD 21015
Is your sales force armed with the most influential oncology publication?
JCO bulk subscriptions are a powerful ally for your marketing programs.
Your sales force can win the respect and appreciation of medical practitioners by consistently delivering authori-tative, respected, and timely information from the pages of Journal of Clinical Oncology.
JCO’s bulk subscription option is the key - your most effective way to put the scholarly findings published in JCO at the fingertips of the professionals you serve. And by expanding JCO’s readership within your organization, you’ll gain access to a superb source of current knowledge and competitive itelligence.
With unsurpassed credibility and value, JCO can truly set you apart.
Journal of Clinical Oncology 2010 Bulk Subscriptions:
Research Objectives: -To track JCO subscribers’ professional information needs and priorities; -To seek subscribers’ input to keep JCO as the leading essential journal in oncology; and -To examine the shifts in their input by practice segments.
Methodology: -6,000 subscribers contacted by email and/or direct mail -No incentive offered
Analysis:
-Response: n=863 (14.4%) -Standard error +/- 4%, 95% probability level
Objectives: -To refresh the results of the previous studies (360° Study from 2003)
-To provide the latest and definitive evidence involving reader priority, readership, reader value and web- based access for the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncologists (ASCO)
-To examine readership, reader value and practice demographics within each specialty separately, and then for all three specialties combined.
-To profile respondents’ practice characteristics, particularly board certification and society membership.
Methodology: -The Matalia Group conducted a direct mail survey among 500 hematologists/oncologists (hemoncs), 500 medical oncologists (oncologists) and 500 radiation oncologists.
-The participants were selected randomly from the mailing list of AMA. 330 Oncologists responded to this study: 105 hemoncs (21%), 111 oncologists (22%) and 114 radiation oncologists (22%).
-A $10 response incentive was provided
-The survey package included a cover letter, a two-page questionnaire which consisted of readership and practice demographics and multiple-choice questions:
-This was a blinded study and there was no mention of ASCO, the Journal of Clinical Oncology (JCO) or The Walchli Tauber Group
Conclusion: -This study collaborates the results of the previous studies The Matalia Group conducted among hemoncs and oncologists.
-It proved that JCO is the highest priority, most useful and most widely respected oncology publication. NEJM is its only serious competitor.
-JCO brings the latest medical advances, assists in clinical decisions and serves as a patient education re source for the largest number of cancer care providers.
-JCO is also one of the most preferred publications for submitting a high impact manuscript. This value is further reflected in the reprints the care providers receive, and the websites they visit.
-Hemoncs are younger, have multiple certifications, and practice mostly in an institutional setting. Their strength is growing, and now they out-number oncologists’. They are members of more organization committees and see more patients.
The Walchli-Tauber Group, Inc. Journal of Clinical Oncology 2225 Old Emmorton Road, Suite 201 Bel Air, MD 21015
(443) 512-8899 (443) 512-8909 fax
Company Information: We are a publisher’s representation firm that was established July, 1998. We specializein partnering with medical societies to maximize their advertising revenue and in working with media buyers andplanners in developing effective strategies for achieving promotional campaign goals.
To contact the sales managers of Journal of Clinical Oncology, click on their email address under the desiredsection. To obtain additional information, please visit our website at www.wt-group.com.
Print/Online Advertising Sales, JCO Production Virtual Meetings & Bulk Subscriptions Roland Keve John Malamphy (443) 512-8899 x101 (443) 512-8899 x104 [email protected][email protected] Classified Advertising JCO Reprints Sandy Bredlow Terry Dennsteadt (443) 512-8899 x108 (443) 512-8899 x107 [email protected][email protected]